Adaptive Introduces Assay to Detect MRD in Blood-Based Cancers
Adaptive will accept clinical samples in its CLIA certified, state-of-the-art immune repertoire sequencing laboratory in 2013
Read MorePosted by Judy O'Rourke | Dec 24, 2012 | Cancer, Miscellaneous, Research |
Adaptive will accept clinical samples in its CLIA certified, state-of-the-art immune repertoire sequencing laboratory in 2013
Read MorePosted by Clinical Lab Products | Dec 5, 2012 | Hematology & Serology, Hematology Instrumentation, Miscellaneous |
The American Society of Hematology will host approximately 20,000 attendees from around the world at its 54th annual meeting and exposition, December 8 to December 11, at the Georgia World Congress Center in Atlanta.
Read MorePosted by Judy O'Rourke | Dec 5, 2012 | Molecular Diagnostics |
Invivoscribe Technologies, a privately-held life science company, introduces Genection Inc, which provides physicians with a dedicated online platform for global access to the entire clinically-actionable genetic test menu.
Read MorePosted by Judy O'Rourke | Nov 12, 2012 | Cancer, Miscellaneous |
The high school science project that could.
Read MorePosted by Clinical Lab Products | Sep 11, 2012 | Cancer, Miscellaneous |
Early treatment response is a powerful predictor of long-term outcome for young patients with acute myeloid leukemia (AML).
Read More